You are on page 1of 2
Key Statistics (as of 04/8/08) Exchange OTCBB Symbol EFSF Market Cap $36.3 M Recent Price

Key Statistics

(as of 04/8/08)

Exchange

OTCBB

Symbol

EFSF

Market Cap

$36.3 M

Recent Price

$0.22

52-Week Range

$0.17-$0.50

Avg. Daily Volume (3m)

344,503

Shares Outstanding

Insider Ownership

165

M

40%

Management

Patricia Gruden

President, CEO

Timothy Matula Director, Corporate Secretary

Richard Goldfarb, M.D., FACS President of MedElite, Inc., a wholly owned subsidiary of EFSF

Robert Bowker President of Knock-Out Technologies, Ltd., a wholly owned subsidiary of EFSF

Investor Relations

The Investor Relations Group 11 Stone Street New York, NY 10004 Tel.: (212) 825-3210 Fax: (212) 825-3229

Investor Relations

Mike Crawford

Emily Hanan

Public Relations Susan Morgenbesser Janet Vasquez

Improving Health Conditions Through Innovative Technologies

Corporate Overview

eFoodSafety.com, Inc., through its wholly owned subsidiaries, is a researcher and developer of whole food nutraceutical and other health-related products that aim to improve common conditions relating to glucose metabolism, cholesterol, acne, and various bacterial pathogens such as E.coli, staphylococcus, and streptococcus. The company continues to formulate new products and recently announced that it has entered the bio- and nano-technologies industry to help improve targeted delivery of its products’ ingredients throughout the body. The company conducts clinical research on all of its products.

eFoodSafety’s business incorporates both consumer rollout of its products as well as ongoing R&D for new products and formulations. On the consumer rollout front, the company has launched direct-response campaigns for two of its products with two scheduled for launch in the near future. eFoodSafety also offers two of its products in retail outlets nationwide. For each of these initiatives, eFoodSafety has partnered with industry experts to help it effectively build its brand and increase sales.

In an EPA required lab test, one of its leading products, formulated entirely of food-grade components, showed a 100% kill rate for the “big six” bacterial health threats: E.coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as avian influenza. The same product recently underwent additional testing in chicken embryos in which it showed efficacy against H5N1, the most virulent form of the avian influenza virus (bird flu).

Consumer Rollout: Direct-Response

eFoodSafety has retained Respond2 Communications Inc., a leading full-service, response-driven advertising agency, to launch direct-response campaigns for three of its products and one joint venture product. Respond2 has successfully spearheaded national television campaigns for well- known consumer product companies including: AOL, Apple, AT&T, H-P, NordicTrack, Philips, P&G, Reebok, Revlon, Sears, Sony, Toshiba, and Weight Watchers, among others.

Benefits of DR:

Targets and appeals to mass audiences

Provides cross-marketing opportunities through coupons and special offers

Offers turnkey solution: Respond2 responsible for managing customer calls, shipping, and other related logistics

Requires little working capital to make products

Limits accounts receivable

Automatically renews customer orders every thirty days

Products being marketed through DR:

Cinnergen®: A non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism; clinically shown to decrease symptoms that commonly accompany elevated blood sugar

Cinnechol™: An all-natural supplement designed promote healthy levels of total cholesterol, LDL (“bad”) cholesterol, and triglycerides without adverse side effects, as well as enhance overall cardiovascular health

NumaDerm™: A skincare line of four products focused on key aspects of skin health and beauty to help maximize healing and rejuvenation; Incorporates a proprietary nanotechnology to efficiently and effectively transport its benefits beneath the skin’s surface

PurEffect™: A four-step acne treatment with advantages over competing solutions; major celebrity endorsements including Maria Menounos and Carmen Electra

7702 East Doubletree Ranch Rd, Ste. 300 Scottsdale, AZ 85258 Tel: (480) 607-2606 Fax: (480) 348-3999 www.efoodsafety.com

Consumer Rollout: Retail Distribution

eFoodSafety recently entered the multi-billion dollar functional food market with its product Immune Boost Bar™, an all-natural nutrition and energy bar designed to promote a healthy immune system. The company’s distribution partners are responsible for marketing the product to major retailers and specialty stores, and their experience includes retail placement for related products such as PowerBar and VitaSoy.

Benefits of retail distribution:

Niche marketing angle: promoting a healthy immune system

Growing bar market in leading retail and specialty stores

The company has sold, and will continue to sell, Cinnergen in retail stores nationwide, including GNC, VitaminShoppe, and Rite Aid.

Financial Highlights

For the quarter ended January 31, 2008:

Revenue increased 300% year-over-year

Sales and marketing expenses decreased 52% year-over-year

Research and development expenses decreased 83% year-over-year

Market Opportunity

Cinnergen

There are currently sixteen million diagnosed and six-to-eight million undiagnosed diabetics living in the United States with 798,000 being newly diagnosed every year (Centers for Disease Control)

Given this large number of diagnosed and undiagnosed pre-diabetics, the size of the diabetes market is estimated to be $132 billion (Cambridge Healthtech Institute)

Cinnechol

An estimated 106.7 million adults in the United States have total blood cholesterol values of 200 mg/dL and higher, and of these about 37.2 million American adults have levels of 240 or above (The American Heart Association)

Immune Boost Bars

Globally, the functional foods market is an estimated $7-63 billion, depending on sources and definitions, and this number is expected reach $167 B by 2010 (AROQ Limited, "Global Market Review of Functional Foods – Forecasts to 2010")

The growth in the functional food market can be explained by consumers who are seeking more healthy lifestyles and solutions for both long and short-term health problems (Food Business Review "Healthy Growth in Functional Food Market Despite Drop in Consumer Trust ," February 2008)

The company expects to rollout the product through several well-known retail distribution channels throughout the country

NumaDerm

The skincare market is expected to reach $7.2 billion by 2010, driven in part by expected double-digit growth of anti-aging products, which is likely to become the second largest category behind hand & body lotions in the industry (Packaged Facts, December 2006)

The "cosmeceutical" market is an estimated $12 billion industry (Packaged Facts, May 2006)

Nano-Encapsulated Products

The Freedonia Group recently projected world demand for nano-materials to reach $4.2 billion by 2011 and $100 billion by 2025, with widespread use in drug delivery applications as a significant growth factor

Research and Development

Nano-Encapsulation Technology:

eFoodSafety uses a novel patented technology that nano-encapsulates active ingredients in nutraceutical and cosmeceutical products to help maximize the body’s cellular absorption of nutrients and minimize toxicity when delivering treatments throughout the body. Using this technology, eFoodSafety can encapsulate a multitude of bioactive and active ingredients.

eFoodSafety remains equally focused on the research and development of new formulas. Recent tests of one of eFoodSafety’s lead products, the natural compound Citroxin™, were conducted at Chulalongkorn University in Bangkok, Thailand, one of the few Asian labs used by the U.S. Centers of Disease Control to conduct research on treatments of H5N1 (the most virulent strain of avian influenza).

Other products in the eFoodSafety pipeline include:

OraPhyte™ – tested and shown to be effective at eradicating nematodes, a phyla that includes more than fifteen thousand parasitic species

Proxorin™ - a natural antibiotic/anti-microbial formulated for use against a broad spectrum of common bacterial pathogens

Disclaimer: The information disseminated by the Investor Relations Group (“IRG,”“us” or “we”) is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. We do not undertake or purport to render any investment advice or recommendations for the buying and selling of securities. Companies that are profiled may have engaged our services to perform investor relation services including promotional services and the placement of the profiled companies on our website. IRG’s compensation for such services has been or will be made in cash and or issuance of securities of the profiled company, the amount or type of compensation is available upon request. We may liquidate any securities that we receive as compensation when deemed appropriate to do so. The assembled information herein is based on information supplied by the company, press releases, SEC filings, or from other sources believed to be reliable as of the date of the report on the featured companies, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. It is subject to change without notice. IRG and its affiliates are not, nor claim to be: brokers, broker-dealers, market makers, investment bankers, advisors, analysts or underwriters. Information in email alerts, Fact Sheets and other forms of informational media provided by us will contain“forward looking statements”as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Forward looking statements are subject to a number of known and unknown risks and uncertainties outside our control that could cause actual operations or results to differ materially from those anticipated. The cautionary statements made herein should be read as being applicable to all related forward-looking statements wherever they appear on this site or in other communications. We encourage you to visit the Securities Exchanges Commission Web site http://www.sec.gov.